Abstract:Abstract Background Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are characterized by a disruption of the endothelium and alveolar epithelial barriers involving increased microvascular permeability, thus resulting in the set of protein-rich pulmonary edema. Angiogenic factors and their receptors, including vascular endothelial growth factor (VEGF)/VEGF-receptor (VEGFR) and the angiopoietin (Ang)/Tie2 signaling pathways, play pivotal roles in both angiogenesis and microvascular permeability. The aim of the study was to assess the relationship between angiogenic factors, their soluble receptors and ALI/ARDS associated with critically ill patients, including sepsis, severe trauma, and post-cardiac arrest syndrome (PCAS). Methods One hundred fifty-nine critically ill patients, including 50 patients with sepsis, 57 patients with severe trauma and 52 resuscitated after out-of-hospital cardiac arrest, were divided into three subgroups: including 25 ALI patients, 101 ARDS patients and 22 non-ALI/ARDS patients. The serum levels of angiogenic factors were measured at the time of admission (day 1), as well as day 3 and day 5 and then were compared among the ALI, ARDS and non-ALI/ARDS groups. Their predictive values for developing ALI/ARDS and 28-day mortality were evaluated. Results Higher levels of sVEGFR1 and Ang2 were observed in the ALI and ARDS patients than in the non-ALI/ARDS patients during the entire study period. The Ang2/Ang1 ratio in the ARDS group was also significantly higher than that in the non-ALI/ADRS group. The sVEGFR2 levels in the ARDS group on day 1 were significantly lower than those of the non-ALI/ADRS group. In addition, significant positive correlations were seen between the sVEGFR1, Ang2, Ang2/Ang1, and the development of ALI/ARDS in critical illness. There were also significant negative correlations between the minimal value of sVEGFR2, the maximal value of Ang1 and the ALI/ARDS group. In particular, sVEGFR2 and Ang2 were independent predictors of developing ALI/ARDS. Moreover, Ang2 and sVEGFR2 also independently predicted the mortality in ALI/ARDS patients. Conclusions Angiogenic factors and their soluble receptors, particularly sVEGFR2 and Ang2, are thus considered to be valuable predictive biomarkers in the development of ALI/ARDS associated with critical illness and mortality in ALI/ARDS patients.

Potential Clinical Application of KGF-2 (FGF-10) for Acute Lung Injury/acute Respiratory Distress Syndrome

Protective Effects of Keratinocyte Growth Factor-2 on Warm Ischemia Reperfusion Lung Injury in Rats

Protective Effects of Keratinocyte Growth Factor-2 on Ischemia–Reperfusion–Induced Lung Injury in Rats

Keratinocyte Growth Factor-2 Intratracheal Instillation Significantly Attenuates Ventilator-Induced Lung Injury in Rats

KGF-2 targets alveolar epithelia and capillary endothelia to reduce high altitude pulmonary oedema in rats

KGF-2 TARGETS ALVEOLAR EPITHELIA AND CAPILLARY ENDOTHELIA TO REDUCE HIGH ALTITUDE PULMONARY EDEMA

KGF-2 Ameliorates Acute Lung Injury Via Inhibiting TH17 Cells-Nf-κb-dependent Inflammation and Activating the PI3K/Akt Survival Signaling Pathway in Mice

Regulatory Effects of Keratinocyte Growth Factor-2 on Acute Lung Inflammatory Injury Induced by Lipopolysaccharide

Keratinocyte Growth Factor-2 Reduces Inflammatory Response to Acute Lung Injury Induced by Oleic Acid in Rats by Regulating Key Proteins of the Wnt/β-Catenin Signaling Pathway

Keratinocyte Growth Factor-2 is Protective in Lipopolysaccharide-Induced Acute Lung Injury in Rats

Glycogen Synthase Kinase-3 Inhibition by CHIR99021 Promotes Alveolar Epithelial Cell Proliferation and Lung Regeneration in the Lipopolysaccharide-Induced Acute Lung Injury Mouse Model

The role of angiogenic factors and their soluble receptors in acute lung injury (ALI)/ acute respiratory distress syndrome (ARDS) associated with critical illness

Novel Interventional Approaches for ALI/ARDS: Cell-Based Gene Therapy

Changes of Keratinocyte and Hepatocyte Growth Factor Contents in Bronchoalveolar Lavage Fluid and Serum in Patients with Acute Lung Injury

Mesenchymal stem cell conditioned medium alleviates acute lung injury through KGF-mediated regulation of epithelial sodium channels

Fibroblast Growth Factor-10 (FGF-10) Mobilizes Lung-resident Mesenchymal Stem Cells and Protects Against Acute Lung Injury

Mechanism and Experimental Verification of Rhodiola rosea L. for the Treatment of Acute Lung Injury Through Network Pharmacology and Molecular Docking

A study of the role of myeloid-derived growth factor on acute lung injury in vitro and In vivo

Role of CCR2 and IL-8 in acute lung injury: a new mechanism and therapeutic target.

Efferocytosis‐Inspired Biomimetic Nanoplatform for Targeted Acute Lung Injury Therapy

Airway Epithelial Dysfunction in the Development of Acute Lung Injury and Acute Respiratory Distress Syndrome.